Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 11 - 02 entities : Pfizer, inc. save search
Transgene Announces Positive Interim Analysis Results of Phase II Trial Evaluating TG4001 + Avelumab vs Avelumab in HPV-Positive Anogenital Cancers
Published: 2022-11-02 (Crawled : 00:00) - biospace.com/
PFE | News 4 | $26.27 -0.19% 0.19% 18M
|
Health Technology
|
| O: -0.5%
H: 0.84%
C: -1.47%
tg4001 trial positive results
Peptide Therapeutics Global Market to Reach $52.19 Billion by 2026 at a CAGR of 8.9%
Published: 2022-11-02 (Crawled : 21:00) - prnewswire.com
SNYNF | News | $94.0 -0.27% -2.18% 310
|
Health Technology
|
| O: -0.7%
H: 0.29%
C: 0.29%
AZNCF | News | $135.35 -3.53% -4.19% 400
|
Health Technology
|
| O: -2.33%
H: 3.2%
C: 3.2%
PFE | News 4 | $26.27 -0.19% 0.19% 18M
|
Health Technology
|
| O: -1.51%
H: 0.95%
C: 0.45%
BMY | $48.86 -0.27% 0.98% 14M
|
Health Technology
|
| O: -0.26%
H: 1.87%
C: 1.59%
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: -1.85%
H: 0.0%
C: 0.0%
AZN | News | $71.2 0.49% 0.46% 5.4M
|
Health Technology
|
| O: -1.31%
H: 1.98%
C: 1.71%
global therapeutics market
Pfizer, Teva Pharmaceuticals, Silverstein Properties and Azrieli Group Honored by the America-Israel Friendship League at its Annual Gala
Published: 2022-11-02 (Crawled : 05:00) - prnewswire.com
PFE | News 4 | $26.27 -0.19% 0.19% 18M
|
Health Technology
|
| O: -0.5%
H: 0.84%
C: -1.47%
teva group
Gainers vs Losers
| 61% | 39% |
Top 10 Gainers
CSSE 4 | $0.4253 179.25% 64.77% 210M
|
Consumer Services
BOF | $2.08 77.78% 41.21% 110M
|
ILAG | $0.54 12.27% 40.62% 3.7M
|
LICN | $0.999 78.39% 40.49% 15M
|
AMST | $3.4 70.0% 39.58% 70M
|
Technology Services
MTC | $3.6 60.71% 38.04% 9.1M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.458 14.5% 30.92% 91K
|
Health Services
WHLM | $6.25 35.87% 28.46% 700K
|
Commercial Services
MULN | News | $3.77 38.1% 27.78% 13M
|
Information
Your saved searches
Save your searches and get alerts when important news are released.